Viewing Study NCT04672005


Ignite Creation Date: 2025-12-25 @ 3:13 AM
Ignite Modification Date: 2026-02-25 @ 8:11 PM
Study NCT ID: NCT04672005
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-05-16
First Post: 2020-11-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Modified FOLFIRINOX Alternated With Biweekly Gemcitabine Plus Nab-Paclitaxel Untreated Pancreatic Cancer
Sponsor: Lyudmyla Berim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module